Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
Reaction mass of 1H-Benzotriazole-1-methanamine, N,N-bis(2-ethylhexyl)-6-methyl- and 2H-Benzotriazole-2-methanamine, N,N-bis(2-ethylhexyl)-5-methyl- and N,N-bis(2-ethylhexyl)-4-methyl-1H-benzotriazole-1-methylamine and 2H-Benzotriazole-2-methanamine, N,N-bis(2-ethylhexyl)-4-methyl- and N,N-bis(2-ethylhexyl)-5-methyl-1H-benzotriazole-1-methylamine
EC number: 939-700-4 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://www.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Description of key information
In the key study, 5 out of 20 guinea pigs gave positive results after challenge exposure and 7 out of 20 after rechallange exposure with the test article. Based on the evaluation criteria of Annex I of Regulation 1272/2008 (CLP), the evalutation " sensitizing" is warranted when at least 30% of the test animals exhibit positive skin reactions in an adjuvant test. Therefore, in line with the above argument, the test article is considered sensitizing after skin contact.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- November 7, 1990 - February 7, 1991
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- The study was conducted in 1991, when the GPMT was the internationally accepted and recommended study type in order to assess sensitizing potential of a substance.
- Species:
- guinea pig
- Strain:
- other: Pirbright White strain (Tif:DHP)
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: from Ciba Geigy Limited, Animal Production, 4332 Stein, Switzerland
- Age at study initiation: approximately 10 weeks
- Weight at study initiation: between 338 and 437 g
- Housing: housed individually in Macrolon cages (Type 3)
- Diet: standard guinea pig pellets (NAFAG no. 845, Gossau SG); ad libitum
- Water: ad libitum
- Acclimation period: 8 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3°C
- Humidity (%): 30 - 70%
- Photoperiod (hrs dark / hrs light): 12/12 - Route:
- intradermal
- Vehicle:
- other: sesame oil
- Concentration / amount:
- 3 %
- Day(s)/duration:
- day 0
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: vaseline
- Concentration / amount:
- 10 %
- Day(s)/duration:
- week 2 / 48 h
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: vaseline
- Concentration / amount:
- 3 %
- Day(s)/duration:
- week 5 / 24 h
- No. of animals per dose:
- 20 (10 males and 10 females)
- Details on study design:
- INDUCTION:
- 2-stage operation
- First induction: 3 pairs of intradermal injections (0.1 mL per injection) made simultaneously into the shaved neck of the guinea pigs as follows:
adjuvant/saline mixture 1:1 (v/v)
test article in sesame oil (3%) (w/v)
test article in the adjuvant saline mixture (w/v)
- Second induction: in the second week, the test article was incorporated in vaseline (10%) (w/w) and applied on a filterpaper patch to the neck of the animals (patch 2 x 4 cm, approximately 0.4 g paste per patch
Occluded administration for 48 hours.
A control group (20 animals: 10 males and 10 females) was treated with adjuvant and the vehicle during the induction period.
REST PERIOD:
no treatment performed during weeks 3 and 4
CHALLENGE:
Animals were tested on the flank with the test article in vaseline (3%) (w/w) or the vehicle alone (patch 2 x 2 cm, approximately 0.2 g paste per patch)
Occluded administration for 24 hours.
During the challenge period, the control group of the induction was treated with the vehicle as well as with the test article to check the maximum subirritant concentration of the test article in adjuvant treated animals. - Challenge controls:
- A control group (20 animals: 10 males and 10 females) was treated with adjuvant and the vehicle during the induction period.
During the challenge period, the group was treated with the vehicle as well as with the test article to check the maximum subirritant concentration of the test article in adjuvant treated animals. - Positive control substance(s):
- yes
- Remarks:
- sensitivity checked every 6 months: potassium dichromate
- Positive control results:
- Incidence of positive animals per group after epidermal challenges 24 hours after removing of bandages:
7/10 for erythema
5/10 for edema - Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 3%
- No. with + reactions:
- 5
- Total no. in group:
- 20
- Clinical observations:
- (effects only in females)
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 3%
- No. with + reactions:
- 5
- Total no. in group:
- 20
- Clinical observations:
- (effects only in females)
- Key result
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 3%
- No. with + reactions:
- 8
- Total no. in group:
- 20
- Clinical observations:
- (3 males, 5 females)
- Key result
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 3%
- No. with + reactions:
- 7
- Total no. in group:
- 20
- Clinical observations:
- (2 males, 5 females)
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 0
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- No toxic symptoms
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 0
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- No toxic symptoms
- Group:
- positive control
- Remarks on result:
- not measured/tested
- Interpretation of results:
- Category 1B (indication of skin sensitising potential) based on GHS criteria
- Conclusions:
- 25 to 40% of the animals were sensitised by the test substance under the experimental conditions employed.
Reference
Results of test group:
Males |
Animal number |
||||||||||
Challenge |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
|
24 h |
Erythema |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Edema |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
48 h |
Erythema |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Edema |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
Re-Challenge |
|
||||||||||
24 h |
Erythema |
1 |
2 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
Edema |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
48 h |
Erythema |
2 |
2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Edema |
1 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Females |
Animal number |
||||||||||
Challenge |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
|
24 h |
Erythema |
0 |
1 |
1 |
0 |
1 |
1 |
1 |
0 |
0 |
0 |
Edema |
0 |
1 |
2 |
0 |
1 |
1 |
1 |
0 |
0 |
0 |
|
48 h |
Erythema |
0 |
1 |
1 |
0 |
1 |
1 |
1 |
0 |
0 |
0 |
Edema |
0 |
0 |
2 |
0 |
1 |
1 |
1 |
0 |
0 |
0 |
|
Re-Challenge |
|
||||||||||
24 h |
Erythema |
0 |
2 |
2 |
1 |
0 |
1 |
2 |
0 |
0 |
0 |
Edema |
0 |
1 |
1 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
|
48 h |
Erythema |
0 |
2s |
2s |
1 |
0 |
2 |
2s |
0 |
0 |
0 |
Edema |
0 |
1 |
1 |
0 |
0 |
1 |
2 |
0 |
0 |
0 |
s = scaling
In both control groups (vehicle control and test article treated control), there were 0/20 animals with positive responses at 24 and 48 hours after challenge.
Under the experimental conditions employed, 25% of the animals of the test group showed skin reactions 24 and 48 hours after removing the dressings.
Because the reactions were not very strong and the number of positive animals was at the threshold of significance, a second challenge was performed after a further rest period. The control group was not challenged again.
After the second challenge application, the number of positive animals was increased to 40% and the reactions intensified.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
In the key dermal sensitisation study with the test substance (99% pure) in sesame oil or vaseline, Pirbright White Strain (Tif: DHP) guinea pigs (10 males and 10 females) were tested using the method of the guinea pig maximisation test according to the OECD TG 406. Intradermal and epicutaneous induction (occlusive, 48 h) was performed with 3% (in sesame oil) and 10% (in vaseline) of the test substance, respectively. Epicutaneous challenge exposure (occlusive, 24 h) was performed with 3% (in vaseline) of the test substance. Evaluation of the skin reactions were performed 24 and 48 hours after challenge according to the Draize method. 5/20 animals showed erythema or edema reactions after the challenge treatment corresponding to 25% with positive results (females: 50%, males: 0%). In a rechallenge, performed one week later, 8/20 and 7/20 animals (24 h and 48 h after treatment, respectively) showed positive reactions corresponding to 40% and 35%. This is above the threshold of 30% laid down in Annex I of Regulation 1272/2008 and therefore the substance is considered a dermal sensitizer in this study. The study is suitable for assessment of sensitizing potential as it was performed according to OECD 406 and GLP standards.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
- Additional information:
No information available on respiratory sensitisation.
Justification for classification or non-classification
Classification, Labelling, and Packaging Regulation (EC) No 1272/2008
The available experimental test data are reliable and suitable for classification purposes under Regulation (EC) No 1272/2008. As a result the substance is considered to be classified as skin sensitizer category 1B (H317: "May cause an allergic reaction") under Regulation (EC) No 1272/2008, as amended for the eighth time in Regulation (EU) No 2016/218.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)